Vanguard Group
BLPH

Vanguard Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-145,810
Closed -$58K 4602
2023
Q3
$58K Hold
145,810
﹤0.01% 4393
2023
Q2
$101K Hold
145,810
﹤0.01% 4391
2023
Q1
$1.15M Hold
145,810
﹤0.01% 3874
2022
Q4
$131K Sell
145,810
-199,384
-58% -$179K ﹤0.01% 4361
2022
Q3
$376K Sell
345,194
-15,596
-4% -$17K ﹤0.01% 4292
2022
Q2
$443K Hold
360,790
﹤0.01% 4318
2022
Q1
$852K Sell
360,790
-9,763
-3% -$23.1K ﹤0.01% 4260
2021
Q4
$1.15M Buy
370,553
+29,098
+9% +$90.1K ﹤0.01% 4230
2021
Q3
$1.39M Buy
341,455
+4,489
+1% +$18.2K ﹤0.01% 4167
2021
Q2
$1.63M Sell
336,966
-22,193
-6% -$107K ﹤0.01% 4029
2021
Q1
$1.86M Sell
359,159
-17,429
-5% -$90.5K ﹤0.01% 3876
2020
Q4
$2.51M Buy
376,588
+22,866
+6% +$153K ﹤0.01% 3603
2020
Q3
$3.6M Sell
353,722
-3,063
-0.9% -$31.2K ﹤0.01% 3303
2020
Q2
$4.48M Buy
356,785
+280,875
+370% +$3.53M ﹤0.01% 3147
2020
Q1
$832K Sell
75,910
-1,036,985
-93% -$11.4M ﹤0.01% 3545
2019
Q4
$389K Hold
1,112,895
﹤0.01% 3842
2019
Q3
$536K Sell
1,112,895
-39,280
-3% -$18.9K ﹤0.01% 3803
2019
Q2
$690K Buy
1,152,175
+158,000
+16% +$94.6K ﹤0.01% 3768
2019
Q1
$649K Buy
994,175
+265,445
+36% +$173K ﹤0.01% 3726
2018
Q4
$584K Sell
728,730
-294,803
-29% -$236K ﹤0.01% 3706
2018
Q3
$1.11M Buy
1,023,533
+25,300
+3% +$27.3K ﹤0.01% 3699
2018
Q2
$2.42M Buy
998,233
+15,905
+2% +$38.5K ﹤0.01% 3441
2018
Q1
$2.04M Buy
982,328
+240,129
+32% +$499K ﹤0.01% 3458
2017
Q4
$1.92M Buy
742,199
+129,558
+21% +$334K ﹤0.01% 3430
2017
Q3
$870K Hold
612,641
﹤0.01% 3619
2017
Q2
$821K Buy
612,641
+211,111
+53% +$283K ﹤0.01% 3611
2017
Q1
$598K Buy
401,530
+347,811
+647% +$518K ﹤0.01% 3719
2016
Q4
$28K Hold
53,719
﹤0.01% 4060
2016
Q3
$75K Sell
53,719
-33,755
-39% -$47.1K ﹤0.01% 4004
2016
Q2
$151K Hold
87,474
﹤0.01% 3982
2016
Q1
$215K Hold
87,474
﹤0.01% 3944
2015
Q4
$259K Hold
87,474
﹤0.01% 3973
2015
Q3
$454K Buy
87,474
+30,300
+53% +$157K ﹤0.01% 3878
2015
Q2
$453K Buy
+57,174
New +$453K ﹤0.01% 3889